<DOC>
	<DOCNO>NCT01900977</DOCNO>
	<brief_summary>PopART community randomize trial investigate whether community-wide combination HIV prevention package include annual home-based HIV testing , active referral offer immediate ART test HIV-positive , along promotion proven HIV prevention method ( voluntary medical male circumcision , prevention mother child transmission condom use ) , help prevent transmission substantially reduce new HIV infection . The study conduct 21 community Zambia South Africa ( randomize 3 arm , 7 community ) total population approximately 1.2 million individual .</brief_summary>
	<brief_title>Population Effects Antiretroviral Therapy Reduce HIV Transmission ( PopART )</brief_title>
	<detailed_description>HIV Prevention Trials Network ( HPTN ) 071 ( PopART ) investigate impact HIV incidence universal voluntary HIV counsel test ( referral care ) provide community house-to-house campaign , combination early ART individual HIV-positive , proven preventive intervention . The design HPTN 071 ( PopART ) allow study team distinguish impact universal test referral HIV care accordance national guideline , impact universal test referral early ART initiation HIV infection . In addition , HPTN 071 ( PopART ) determine program universal voluntary testing , include early ART initiation , feasible acceptable deliver large scale entire community . Evaluating effectiveness universal voluntary HIV counsel test offer early ART key global health priority .</detailed_description>
	<criteria>1 . Population Cohort 1 . 18 44 year age 2 . Able willing provide inform consent 3 . Residing within catchment area designate local health unit intend remain next three year 4 . Residing randomly select household 2 . CaseControl Study 1 1 . At least 18 year age 2 . Able willing provide inform consent 3 . Resident cluster first round test 4 . Visited CHiP team offer test first round homebased test 3 . CaseControl Study 2 1 . At least 18 year age 2 . Able willing provide inform consent 3 . Resident cluster first round test 4 . Tested HIVinfected CHiP homebased test , HIVinfected disclose previously diagnose HIVinfected CHiP team 4 . CaseControl Study 3 1 . At least 18 year age 2 . Able willing provide inform consent 3 . Resident cluster second round test 4 . Visited CHiP team offer test second round homebased test 1 . Population Cohort 1 . Current plan enrollment another HIV treatment , prevention , PreExposure Prophylaxis ( PrEP ) study 2 . Current , plan prior enrollment HIV vaccine study 3 . Anything , opinion investigator , would preclude informed consent , make study participation unsafe , complicate interpretation study outcome data , otherwise interfere achieve study objective . 2 . CaseControl Study 1 1 . Individuals belong Population Cohort casecontrol study 2 . Individuals know HIVinfected test elsewhere . 3 . CaseControl Study 2 1 . Individuals enrol Population Cohort casecontrol study 2 . HIVinfected individual already ART study commences 4 . CaseControl Study 3 1 . Known HIV infect CHiP data . 2 . Individuals belong Population Cohort casecontrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Universal Test Treat ( UTT )</keyword>
	<keyword>Combination Prevention</keyword>
</DOC>